Sphingosine-1-phosphate signaling and its role in disease

Olivera, 1993, Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens, Nature, 365, 557, 10.1038/365557a0

Cuvillier, 1996, Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate, Nature, 381, 800, 10.1038/381800a0

Spiegel, 2011, The outs and the ins of sphingosine-1-phosphate in immunity, Nat. Rev. Immunol., 11, 403, 10.1038/nri2974

Pitson, 2010, Regulation of sphingosine kinase and sphingolipid signaling, Trends Biochem. Sci., 36, 97, 10.1016/j.tibs.2010.08.001

Jarman, 2010, Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1, J. Biol. Chem., 285, 483, 10.1074/jbc.M109.068395

Leclercq, 2011, Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis, Oncogene, 30, 372, 10.1038/onc.2010.420

Hait, 2009, Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, 325, 1254, 10.1126/science.1176709

Strub, 2011, Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration, FASEB J., 25, 600, 10.1096/fj.10-167502

Don, 2009, A lipid binding domain in sphingosine kinase 2, Biochem. Biophys. Res. Commun., 380, 87, 10.1016/j.bbrc.2009.01.075

Hait, 2007, Sphingosine kinase type 2 activation by ERK-mediated phosphorylation, J. Biol. Chem., 282, 12058, 10.1074/jbc.M609559200

Ding, 2007, Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2, J. Biol. Chem., 282, 27493, 10.1074/jbc.M701641200

Schnitzer, 2009, Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells, Mol. Cancer Res., 7, 393, 10.1158/1541-7786.MCR-08-0156

Wacker, 2009, Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2, Stroke, 40, 3342, 10.1161/STROKEAHA.109.560714

Schwab, 2007, Finding a way out: lymphocyte egress from lymphoid organs, Nat. Immunol., 8, 1295, 10.1038/ni1545

Brinkmann, 2010, Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis, Nat. Rev. Drug Discov., 9, 883, 10.1038/nrd3248

Pham, 2008, S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress, Immunity, 28, 122, 10.1016/j.immuni.2007.11.017

Cyster, 2010, B cell follicles and antigen encounters of the third kind, Nat. Immunol., 11, 989, 10.1038/ni.1946

Jenne, 2009, T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow, J. Exp. Med., 206, 2469, 10.1084/jem.20090525

Allende, 2011, Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking, J. Biol. Chem., 286, 7348, 10.1074/jbc.M110.171819

Pitson, 2009, Regulation of stem cell pluripotency and neural differentiation by lysophospholipids, Neurosignals, 17, 242, 10.1159/000231891

Camerer, 2009, Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice, J. Clin. Invest., 119, 1871

Scherer, 2010, Tumor necrosis factor-alpha enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling, Stroke, 41, 2618, 10.1161/STROKEAHA.110.593327

Kono, 2007, Deafness and stria vascularis defects in S1P2 receptor null mice, J. Biol. Chem., 282, 10690, 10.1074/jbc.M700370200

Maclennan, 2006, The S1P(2) sphingosine 1-phosphate receptor is essential for auditory and vestibular function, Hear. Res., 220, 38, 10.1016/j.heares.2006.06.016

Sato, 2007, Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes, J. Neurochem., 103, 2610, 10.1111/j.1471-4159.2007.04958.x

Mitra, 2006, Role of ABCC1 in export of sphingosine-1-phosphate from mast cells, Proc. Natl. Acad. Sci. U.S.A., 103, 16394, 10.1073/pnas.0603734103

Takabe, 2010, Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2, J. Biol. Chem., 285, 10477, 10.1074/jbc.M109.064162

Kawahara, 2009, The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors, Science, 323, 524, 10.1126/science.1167449

Schwab, 2005, Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients, Science, 309, 1735, 10.1126/science.1113640

Berdyshev, 2011, Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase, PLoS ONE, 6, e16571, 10.1371/journal.pone.0016571

Siow, 2010, Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate, J. Lipid Res., 51, 2546, 10.1194/jlr.M004374

Bagdanoff, 2010, J. Med. Chem., 53, 8650, 10.1021/jm101183p

Spiegel, 2003, Sphingosine-1-phosphate: an enigmatic signalling lipid, Nat. Rev. Mol. Cell Biol., 4, 397, 10.1038/nrm1103

Ghosh, 1990, Intracellular calcium release mediated by sphingosine derivatives generated in cells, Science, 248, 1653, 10.1126/science.2163543

Ghosh, 1994, Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium, J. Biol. Chem., 269, 22628, 10.1016/S0021-9258(17)31692-7

Mattie, 1994, Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway, J. Biol. Chem., 269, 3181, 10.1016/S0021-9258(17)41846-1

Xia, 2002, Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling, J. Biol. Chem., 277, 7996, 10.1074/jbc.M111423200

Alvarez, 2010, Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2, Nature, 465, 1084, 10.1038/nature09128

Puneet, 2010, SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis, Science, 328, 1290, 10.1126/science.1188635

Artal-Sanz, 2009, Prohibitin and mitochondrial biology, Trends Endocrinol. Metab., 20, 394, 10.1016/j.tem.2009.04.004

Takasugi, 2011, BACE1 activity is modulated by cell-associated sphingosine-1-phosphate, J. Neurosci., 31, 6850, 10.1523/JNEUROSCI.6467-10.2011

Chi, 2011, Sphingosine-1-phosphate and immune regulation: trafficking and beyond, Trends Pharmacol. Sci., 32, 16, 10.1016/j.tips.2010.11.002

Pyne, 2010, Sphingosine 1-phosphate and cancer, Nat. Rev. Cancer, 10, 489, 10.1038/nrc2875

Guan, 2011, Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells, PLoS ONE, 6, e19946, 10.1371/journal.pone.0019946

Salas, 2011, Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A, Blood, 117, 5941, 10.1182/blood-2010-08-300772

Kim, 2011, Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-G{alpha}q coupling, J. Cell Sci., 124, 2220, 10.1242/jcs.076794

Anelli, 2010, Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro, FASEB J., 24, 2727, 10.1096/fj.09-150540

Lee, 2010, STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors, Nat. Med., 16, 1421, 10.1038/nm.2250

Dickson, 2011, A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors, Clin. Cancer Res., 17, 2484, 10.1158/1078-0432.CCR-10-2323

Paugh, 2008, A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia, Blood, 112, 1382, 10.1182/blood-2008-02-138958

Kapitonov, 2009, Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts, Cancer Res., 69, 6915, 10.1158/0008-5472.CAN-09-0664

Song, 2011, Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-kappaB pathway in human non-small cell lung cancer, Clin. Cancer Res., 17, 1839, 10.1158/1078-0432.CCR-10-0720

Loveridge, 2010, The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells, J. Biol. Chem., 285, 38841, 10.1074/jbc.M110.127993

Antoon, 2011, Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer, J. Mol. Endocrinol., 46, 205, 10.1530/JME-10-0116

Kennedy, 2011, Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells, J. Med. Chem., 54, 3524, 10.1021/jm2001053

Van Brocklyn, 2005, Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines, J. Neuropathol. Exp. Neurol., 64, 695, 10.1097/01.jnen.0000175329.59092.2c

Sankala, 2007, Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin, Cancer Res., 67, 10466, 10.1158/0008-5472.CAN-07-2090

Weigert, 2009, Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype, Int. J. Cancer., 125, 2114, 10.1002/ijc.24594

French, 2010, Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2, J. Pharmacol. Exp. Ther., 333, 129, 10.1124/jpet.109.163444

Antoon, 2010, Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640, Endocrinology, 151, 5124, 10.1210/en.2010-0420

Daum, 2009, Sphingosine 1-phosphate: a regulator of arterial lesions, Arterioscler. Thromb. Vasc. Biol., 29, 1439, 10.1161/ATVBAHA.108.175240

Sato, 2010, Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein, World J. Biol. Chem., 1, 327, 10.4331/wjbc.v1.i11.327

Keul, 2011, Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis, Circ. Res., 108, 314, 10.1161/CIRCRESAHA.110.235028

Wang, 2010, Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice, J. Clin. Invest., 120, 3979, 10.1172/JCI42315

Skoura, 2011, Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 31, 81, 10.1161/ATVBAHA.110.213496

Christoffersen, 2011, Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M, Proc. Natl. Acad. Sci. U.S.A., 108, 9613, 10.1073/pnas.1103187108

Nofer, 2007, FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice, Circulation, 115, 501, 10.1161/CIRCULATIONAHA.106.641407

Keul, 2007, The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 27, 607, 10.1161/01.ATV.0000254679.42583.88

Blom, 2010, FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages, Circ. Res., 106, 720, 10.1161/CIRCRESAHA.109.204396

Summers, 2010, Sphingolipids and insulin resistance: the five Ws, Curr. Opin. Lipidol., 21, 128, 10.1097/MOL.0b013e3283373b66

Deevska, 2011, The twists and turns of sphingolipid pathway in glucose regulation, Biochimie, 93, 32, 10.1016/j.biochi.2010.05.016

Holland, 2011, Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice, J. Clin. Invest., 121, 1858, 10.1172/JCI43378

Holland, 2011, Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin, Nat. Med., 17, 55, 10.1038/nm.2277

Fox, 2011, Circulating sphingolipid biomarkers in models of type 1 diabetes, J. Lipid Res., 52, 509, 10.1194/jlr.M010595

Imasawa, 2010, Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells, Biochem. Biophys. Res. Commun., 392, 207, 10.1016/j.bbrc.2010.01.016

Raisz, 2005, Pathogenesis of osteoporosis: concepts, conflicts, and prospects, J. Clin. Invest., 115, 3318, 10.1172/JCI27071

Ryu, 2006, Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling, EMBO J., 25, 5840, 10.1038/sj.emboj.7601430

Pederson, 2008, Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate, Proc. Natl. Acad. Sci. U.S.A., 105, 20764, 10.1073/pnas.0805133106

Ishii, 2009, Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis, Nature, 458, 524, 10.1038/nature07713

Ishii, 2010, Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo, J. Exp. Med., 207, 2793, 10.1084/jem.20101474

Baker, 2010, Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis, J. Immunol., 185, 2570, 10.4049/jimmunol.1000644

Reines, 2009, Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration, J. Invest. Dermatol., 129, 1954, 10.1038/jid.2008.454

Tsunemi, 2010, Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model, Clin. Immunol., 136, 197, 10.1016/j.clim.2010.03.428

Kurashima, 2007, Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy, J. Immunol., 179, 1577, 10.4049/jimmunol.179.3.1577

Guillermet-Guibert, 2009, Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug, Mol. Cancer Ther., 8, 809, 10.1158/1535-7163.MCT-08-1096

Ricci, 2009, In vitro anti-leukaemia activity of sphingosine kinase inhibitor, Br. J. Haematol., 144, 350, 10.1111/j.1365-2141.2008.07474.x

Nishiuma, 2008, Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model, Am. J. Physiol. Lung Cell. Mol. Physiol., 294, L1085, 10.1152/ajplung.00445.2007

Fitzpatrick, 2011, Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase, Inflammopharmacology, 19, 75, 10.1007/s10787-010-0060-6

Chumanevich, 2010, Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase, Carcinogenesis, 31, 1787, 10.1093/carcin/bgq158

Beljanski, 2011, Combined anticancer effects of sphingosine kinase inhibitors and sorafenib, Invest. New Drugs, 29, 1132, 10.1007/s10637-010-9452-0

Chiba, 2010, SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice, J. Pharmacol. Sci., 114, 304, 10.1254/jphs.10202FP

Bandhuvula, 2011, S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart, Am. J. Physiol. Heart Circ. Physiol., 300, H1753, 10.1152/ajpheart.00946.2010

Zhao, 2011, Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression, Am. J. Respir. Cell Mol. Biol., 45, 426, 10.1165/rcmb.2010-0422OC

Awad, 2011, Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes, Kidney Int., 79, 1090, 10.1038/ki.2010.544

Bajwa, 2010, Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury, J. Am. Soc. Nephrol., 21, 955, 10.1681/ASN.2009060662

Diab, 2010, Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema, Am. J. Respir. Crit. Care Med., 181, 344, 10.1164/rccm.200906-0826OC

Hasegawa, 2010, Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats, Stroke, 41, 368, 10.1161/STROKEAHA.109.568899

Kim, 2009, Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy, J. Neuroimmunol., 214, 93, 10.1016/j.jneuroim.2009.07.006

Marsolais, 2009, A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection, Proc. Natl. Acad. Sci. U.S.A., 106, 1560, 10.1073/pnas.0812689106

Niessen, 2009, Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality, Blood, 113, 2859, 10.1182/blood-2008-12-192385

Pan, 2006, A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model, Chem. Biol., 13, 1227, 10.1016/j.chembiol.2006.09.017

Zhang, 2009, AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis, J. Neuroimmunol., 216, 59, 10.1016/j.jneuroim.2009.09.010

Oskeritzian, 2010, Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema, J. Exp. Med., 207, 465, 10.1084/jem.20091513